Skip to content

No match scores

Peptide finder

Pick what you want to change. See every compound measured for it in people, most people first. Each one shows what the study found, and the failures are counted.

Plate 11

Goal map

Find by outcome

Fat lossRecoverySleepSkinLongevityThe record

36

Goal pages

1

Record

Pick your goal. What was measured opens up, including the gaps.

The short answer

Pick what you want to change. See every compound measured for it in people, most people first. Each one shows what the study found, and the failures are counted. 70 of 453 compounds here have no study in people of any kind.

Compounds
453
No study in people
70

How this ranks

No match scores

Other tools print a match percentage. Nobody measured those numbers. This page shows how many people each goal was measured in, and names the goals nobody has measured in a person.

A thin record in people is usually about who pays for trials. It is not a verdict on the compound.

What users report sits next to the trial count. It is never added into it.

What are you trying to change?

Pick as many as you like. The number on each one is how many people it has been measured in across the whole archive. So you can see where the evidence is before you choose.

Somebody handed you a stack. What is actually known about it?

Add what you are looking at. You get every goal those compounds have been measured for in people. Then you get the longer list of goals they have not.

Joint and knee pain

Will it help my knees?

One of the two things people most often report trying peptides for, and one of the thinnest human evidence bases on this site.

1,127 people · 6 studies in people · 5 compounds

  1. 01MelittinPeptideModerate. At least one finished study in people, and at least 100 people who took it. 5 completed trials, 658 people given it.4 reported
    538 people1 study

    • This tested whole bee venom, not melittin. Five hundred and thirty eight people with knee arthritis got weekly skin injections of venom, or of a control substance, for twelve weeks. Pain and physical function improved more on the venom. The gains were modest in size. Reactions where the needle went in were uncommon....

      Journal of Alternative and Complementary Medicine, 2019 · 538 people

  2. 02MethotrexateSmall moleculeStrong. At least two finished studies in people, and at least 1,000 people who took it. 2 completed trials, 5,022 people given it.4 reported
    236 people1 study

    • A year of methotrexate given before rheumatoid arthritis was diagnosed did not stop the arthritis from arriving. 236 adults with joint pain took part. They also got one steroid shot at the start. They did have less pain, stiffness and joint inflammation two years on. One region, and an early test of the idea.

      The Lancet, 2022 · 236 people

  3. 03UBX0101Small moleculeModerate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 183 people given it.3 reported
    183 people1 study

    • The first clean-up drug ever tested against a real symptom in people failed. 183 people with knee arthritis got one shot of UBX0101 at one of three strengths, or a dummy shot. After 12 weeks, knee pain had fallen from about 2.1 to 1.12 on the dummy shot and to between 1.04 and 1.16 on the drug. Knee function and daily...

      ClinicalTrials.gov, 2026 · 183 people

  4. 04CurcuminSupplementModerate. At least one finished study in people, and at least 100 people who took it. 3 completed trials, 195 people given it.5 reported
    95 people2 studies

    • A high-absorption curcumin form eased knee pain in a short study. 50 adults with knee arthritis took 180 mg a day, or a dummy pill, for 8 weeks. Pain scores were lower on the curcumin form, except in people who started with almost no pain. They also needed less of the pain drug celecoxib. Eight weeks is short, and...

      Journal of Orthopaedic Science, 2014 · 50 people

    • A very small rheumatoid arthritis pilot put 45 people on curcumin, a pain drug (diclofenac), or both. Disease scores improved in all three groups, and the curcumin-only group improved most. 45 people split three ways cannot settle a long-term disease. Treat it as a reason to run a proper study, not as proof.

      Phytotherapy Research, 2012 · 45 people

  5. 05Alpha-2-MacroglobulinBiologicLimited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, 75 people given it.6 reported
    75 people1 study1 found nothing

    • found nothingA2M injections helped knees, but no better than the cheaper options they were tested against. 75 people with moderate knee osteoarthritis were split by chance between an A2M-rich concentrate, ordinary platelet-rich plasma, and a steroid injection. Nobody involved knew which. 68 finished. At 12 weeks the A2M group had...

      Bulletin of the Hospital for Joint Diseases, 2024 · 75 people

  6. 06PiperlongumineSmall moleculeAnimal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, 3 lab studies, no human study.2 reported
    number of people not given0 studies

    • In rats. Piperlongumine cut signs of worn-out cells in knee tissue and slowed knee arthritis. The researchers also tested cells taken from people with arthritis, but only in a dish. No patients were treated.

      Biochemical and Biophysical Research Communications, 2026 · number of people not given

  7. 07CartalaxPeptideAnimal or lab only. Only animal or lab studies on this page. No study in people yet. 4 lab studies, no human study.8 reported
    number of people not given0 studies

    • In a dish. Aging cartilage cells gave off more aging and inflammation signals. Both Cartalax and a cartilage extract pushed those signals back toward normal. These were cells, not joints, and nobody measured a real health result.

      Advances in Gerontology, 2023 · number of people not given

  8. 08Nandrolone decanoateHormoneLimited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, none stating how many people.6 reported
    number of people not given0 studies
    • 09BPC-157PeptideLimited. People have taken it in a published study, but fewer than 100 of them. 3 completed trials, 31 people given it.10 reported
      number of people not given0 studies
      • 10RapamycinSmall moleculeLimited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 25 people given it.8 reported
        number of people not given0 studies
        • 11GLOW blendBlendLimited. People have taken it in a published study, but fewer than 100 of them. 2 completed trials, 22 people given it.9 reported
          number of people not given0 studies
          • 12Rapamycin plus acarboseSmall moleculeAnimal or lab only. Only animal or lab studies on this page. No study in people yet. 7 animal studies, no human study.5 reported
            number of people not given0 studies
            • 13Testosterone cypionateHormoneModerate. At least one finished study in people, and at least 100 people who took it. 1 completed trial, 5,246 people given it.9 reported
              number of people not given0 studies
              • 14Deadpool blendBlendAnimal or lab only. Only animal or lab studies on this page. No study in people yet. 1 animal study, 1 lab study, no human study.7 reported
                number of people not given0 studies
                • 15PDA with TB-500BlendAnimal or lab only. Only animal or lab studies on this page. No study in people yet. 1 lab study, no human study.6 reported
                  number of people not given0 studies
                  • 16Semaglutide with BPC-157BlendLimited. People have taken it in a published study, but fewer than 100 of them. 1 completed trial, none stating how many people.7 reported
                    number of people not given0 studies

                    How this is counted

                    Studies in people only. Animal and lab work never goes into this ranking, because your question was about a person.

                    A compound is listed for a goal only when a study on its own page names that goal and reports a result for it. Just naming it is not enough. Say a paper measures testosterone but reports a result about something else. That does not count as testosterone evidence. This tool made that mistake on its first run, and it no longer does.

                    People counts come from the study lines themselves, and when in doubt they count low. If a line gives no number, the study still counts as a study but adds nobody to the people count. Counts are never added up across compounds, because the same person can be in more than one trial.

                    The order is by how many people were measured. That is a fact about the evidence, not a judgement about the compound. It is the only order this site will defend. A compound at the top of a list is the most studied. That is not the same as the best.

                    Nothing here is advice. Nothing here tells you to take anything.

                    How we grade evidence